Income Statement Sinoma Science & Technology Co.,Ltd.

Equities

002080

CNE000001P78

Specialty Chemicals

End-of-day quote Shenzhen S.E. Other stock markets 2026-04-10			5-day change	1st Jan Change
45.58 ^CNY	+5.78%		+14.75%	+25.43%

Mar. 20	Sinoma Science & Technology 2025 Profit Jumps 104%, Revenue Up 26%	MT
Mar. 19	Sinoma Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

23b9a30a1ab35d1db5cd677b145.Os64uRCKqPMEDt0vstn1vAstASvkdfcmwNp5k6rWhWQ.YquM_Grj24ddae5H3aHG8GN7Q0iMO5lhspQL5uSg7QpchM7bc97OxUNGiA

Published financial data: SINOMA SCIENCE & TECHNOLOGY CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	19.86B	21.59B	25.19B	23.21B	29.58B
Other Revenues, Total	440M	514M	704M	778M	618M
Total Revenues	20.3B	22.11B	25.89B	23.98B	30.2B
Cost of Goods Sold, Total	14.27B	16.53B	19.73B	19.98B	24.59B
Gross Profit	6.03B	5.57B	6.16B	4B	5.6B
Selling General & Admin Expenses, Total	1.26B	1.28B	1.77B	1.61B	1.78B
Provision for Bad Debts	579K	-20.57M	28.04M	70.92M	56.75M
R&D Expenses	961M	1.06B	1.3B	1.27B	1.5B
Other Operating Expenses	116M	196M	218M	232M	261M
Other Operating Expenses, Total	2.34B	2.51B	3.32B	3.18B	3.59B
Operating Income	3.69B	3.06B	2.84B	822M	2.01B
Interest Expense, Total	-459M	-497M	-405M	-396M	-365M
Interest And Investment Income	72.23M	164M	61.45M	110M	40.38M
Net Interest Expenses	-387M	-333M	-343M	-286M	-325M
Currency Exchange Gains (Loss)	-36.43M	89.37M	28.96M	18.01M	4.7M
Other Non Operating Income (Expenses)	4.11M	-20.93M	-35.28M	-26.14M	-23.75M
EBT, Excl. Unusual Items	3.27B	2.8B	2.49B	528M	1.66B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	13.22M	-14.26M	-819K	-2.08M
Gain (Loss) On Sale Of Assets	681M	1.08B	62.35M	-3.52M	150M
Asset Writedown	-82.5M	-100M	-21.84M	-15.35M	-114M
Insurance Settlements	10.32M	3.91M	6.04M	34.52M	771K
Legal Settlements	-8M	-	-	-	-
Other Unusual Items	251M	275M	513M	678M	648M
EBT, Incl. Unusual Items	4.12B	4.07B	3.04B	1.22B	2.35B
Income Tax Expense	649M	335M	322M	96.63M	257M
Earnings From Continuing Operations	3.48B	3.73B	2.72B	1.12B	2.09B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	3.48B	3.73B	2.72B	1.12B	2.09B
Minority Interest	-102M	-220M	-492M	-232M	-271M
Net Income - (IS)	3.37B	3.51B	2.22B	892M	1.82B
Net Income to Common Incl Extra Items	3.37B	3.51B	2.22B	892M	1.82B
Net Income to Common Excl. Extra Items	3.37B	3.51B	2.22B	892M	1.82B
Per Share Items
Net EPS - Basic	2.01	2.09	1.33	0.53	1.08
Basic EPS - Continuing Operations	2.01	2.09	1.33	0.53	1.08
Basic Weighted Average Shares Outstanding	1.68B	1.68B	1.68B	1.68B	1.68B
Net EPS - Diluted	2.01	2.09	1.33	0.53	1.08
Diluted EPS - Continuing Operations	2.01	2.09	1.33	0.53	1.08
Diluted Weighted Average Shares Outstanding	1.68B	1.68B	1.68B	1.68B	1.68B
Normalized Basic EPS	1.16	0.91	0.64	0.06	0.46
Normalized Diluted EPS	1.16	0.91	0.64	0.06	0.46
Dividend Per Share	0.64	0.66	0.56	0.22	0.43
Payout Ratio	39.23	43.4	67.39	136.26	43.84
Supplemental Items
EBITDA	4.92B	4.51B	4.55B	2.81B	4.25B
EBITA	3.78B	3.18B	2.96B	992M	2.18B
EBIT	3.69B	3.06B	2.84B	822M	2.01B
EBITDAR	4.95B	4.57B	4.62B	2.91B	4.33B
Total Revenues (As Reported)	20.3B	22.11B	25.89B	23.98B	30.2B
Effective Tax Rate - (Ratio)	15.73	8.23	10.59	7.91	10.96
Total Current Taxes	660M	479M	282M	139M	447M
Total Deferred Taxes	-11.48M	-145M	39.56M	-42.11M	-190M
Normalized Net Income	1.94B	1.53B	1.07B	97.38M	768M
Interest Capitalized	25.18M	7.61M	35.97M	106M	75.43M
Interest on Long-Term Debt	94.78M	132M	126M	137M	92.26M
Non-Cash Pension Expense	-	-	-	19.69M	13.56M
Supplemental Operating Expense Items
Advertising Expense	4.09M	2.56M	8.7M	13.3M	12.2M
Marketing Expenses	12.14M	8.01M	26.65M	7.8M	6.88M
Selling and Marketing Expenses	283M	297M	494M	245M	256M
General and Administrative Expenses	965M	970M	1.26B	1.31B	1.49B
Research And Development Expense From Footnotes	1.01B	1.11B	1.32B	1.31B	1.52B
Net Rental Expense, Total	37.59M	57.04M	66.53M	95.54M	73.97M
Imputed Operating Lease Interest Expense	12.94M	19.28M	16.82M	23.59M	15.1M
Imputed Operating Lease Depreciation	24.65M	37.76M	49.7M	71.96M	58.88M
Maintenance & Repair Expenses, Total	19.65M	20.73M	28.14M	32.84M	27.86M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.63B	5.78B	3.54B	2.74B	3.1B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	2.63B	5.78B	3.54B	2.74B	3.1B
Accounts Receivable, Total	8.74B	9.84B	12.3B	11.52B	14.25B
Other Receivables	100M	122M	408M	494M	383M
Total Receivables	8.84B	9.96B	12.71B	12.02B	14.63B
Inventory	2.25B	3.18B	3.9B	3.58B	4.67B
Prepaid Expenses	1.07M	3.06M	1.41M	20.36M	32.05M
Other Current Assets, Total	655M	515M	1.12B	1.51B	1.54B
Total Current Assets	14.38B	19.44B	21.28B	19.88B	23.97B
Gross Property Plant And Equipment	26.6B	50.7B	40.66B	46.07B	48.93B
Accumulated Depreciation	-6.6B	-26.69B	-9.4B	-10.64B	-12.54B
Net Property Plant And Equipment	20B	24.02B	31.26B	35.42B	36.39B
Long-term Investments	348M	470M	624M	670M	1.01B
Goodwill	48.27M	48.27M	48.27M	48.27M	48.27M
Other Intangibles, Total	1.28B	1.52B	2.2B	2.21B	2.16B
Deferred Tax Assets Long-Term	254M	504M	572M	635M	832M
Deferred Charges Long-Term	304M	410M	440M	390M	668M
Other Long-Term Assets, Total	1.01B	482M	381M	605M	510M
Total Assets	37.63B	46.89B	56.81B	59.86B	65.59B
Liabilities
Accounts Payable, Total	7.17B	8.76B	11.01B	11.83B	16.5B
Accrued Expenses, Total	843M	1B	1.11B	963M	847M
Short-term Borrowings	2.08B	1.81B	865M	2.88B	4.35B
Current Portion of Long-Term Debt	2.55B	914M	4.57B	2.99B	2.91B
Current Portion of Leases	9.38M	25.78M	27.1M	57.39M	66.32M
Current Income Taxes Payable	207M	113M	89.79M	46.17M	180M
Unearned Revenue Current, Total	361M	339M	501M	706M	387M
Other Current Liabilities	359M	312M	936M	1.03B	649M
Total Current Liabilities	13.58B	13.28B	19.11B	20.49B	25.89B
Long-Term Debt	6.66B	9.69B	9.61B	11.11B	9.65B
Long-Term Leases	32.98M	123M	189M	259M	278M
Unearned Revenue Non Current	1.29B	734M	810M	786M	958M
Deferred Tax Liability Non Current	40.78M	146M	160M	181M	188M
Other Non Current Liabilities	407M	378M	431M	302M	287M
Total Liabilities	22.02B	24.34B	30.31B	33.13B	37.25B
Common Stock, Total	1.68B	1.68B	1.68B	1.68B	1.68B
Additional Paid In Capital	4.44B	5.1B	5.09B	5.09B	5.05B
Retained Earnings	8.04B	10.49B	11.78B	11.73B	13.17B
Comprehensive Income and Other	4.31M	11.83M	16.53M	8.96M	8.28M
Total Common Equity	14.17B	17.27B	18.56B	18.51B	19.91B
Minority Interest	1.44B	5.27B	7.93B	8.22B	8.43B
Total Equity	15.61B	22.55B	26.5B	26.74B	28.34B
Total Liabilities And Equity	37.63B	46.89B	56.81B	59.86B	65.59B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.68B	1.68B	1.68B	1.68B	1.68B
ECS Total Common Shares Outstanding	1.68B	1.68B	1.68B	1.68B	1.68B
Book Value / Share	8.44	10.29	11.06	11.03	11.87
Tangible Book Value	12.84B	15.71B	16.31B	16.25B	17.7B
Tangible Book Value Per Share	7.65	9.36	9.72	9.68	10.55
Total Debt	11.34B	12.56B	15.26B	17.29B	17.25B
Net Debt	8.7B	6.78B	11.71B	14.55B	14.15B
Debt Equivalent Oper. Leases	301M	456M	532M	764M	592M
Minority Interest, Total (Incl. Fin. Div)	1.44B	5.27B	7.93B	8.22B	8.43B
Equity Method Investments, Total	343M	153M	307M	353M	694M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	324M	464M	787M	730M	782M
Inventories - Work In Process, Total	652M	841M	1.16B	1.12B	1.13B
Inventories - Finished Goods, Total	1.37B	1.97B	2.13B	1.97B	2.94B
Inventories - Others	16.74M	32.02M	68.78M	48.84M	27.41M
Buildings, Total	5.54B	5.64B	7.71B	7.59B	9.15B
Machinery, Total	18.71B	40.61B	25.89B	26.83B	37.15B
Full Time Employees	18.52K	20.73K	24.14K	19.96K	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	233M	214M	423M	471M	527M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	3.37B	3.51B	2.22B	892M	1.82B
Depreciation & Amortization - CF	1.15B	1.36B	1.63B	1.88B	2.14B
Amortization of Goodwill and Intangible Assets - (CF)	89.94M	114M	121M	170M	169M
Depreciation & Amortization, Total	1.24B	1.47B	1.75B	2.05B	2.31B
Amortization of Deferred Charges, Total - (CF)	53.79M	99.14M	58.09M	119M	134M
(Gain) Loss From Sale Of Asset	-681M	-1.08B	-62.35M	3.52M	-150M
(Gain) Loss on Sale of Investments - (CF)	-47.9M	-133M	14.26M	-76.92M	2.08M
Asset Writedown & Restructuring Costs	82.5M	100M	19.33M	9.06M	108M
Provision for Credit Losses	-	-	-	-	-
Provision and Write-off of Bad Debts	-36.36M	-24.12M	28.04M	70.92M	56.75M
Other Operating Activities, Total	617M	774M	1.1B	683M	759M
Change In Accounts Receivable	-1.1B	-759M	-145M	351M	-2.7B
Change In Inventories	629K	-981M	-350M	255M	-1.18B
Change In Accounts Payable	187M	322M	144M	-717M	4.43B
Change In Deferred Taxes	-11.48M	-145M	39.56M	-42.51M	-188M
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	3.67B	3.16B	4.82B	3.6B	5.4B
Capital Expenditure	-1.8B	-4.54B	-7.77B	-4.56B	-3.55B
Sale of Property, Plant, and Equipment	111M	814M	129M	16.69M	191M
Cash Acquisitions	-	-	-	-	-
Divestitures	-	9.76M	-	71.59M	9.76M
Investment in Marketable and Equity Securities, Total	51.03M	915K	119M	-61.68M	-354M
Other Investing Activities, Total	88.78M	51.03M	6.66M	29.41M	11.71M
Cash from Investing	-1.55B	-3.66B	-7.51B	-4.51B	-3.7B
Short Term Debt Issued, Total	294M	165M	126M	-	-
Long-Term Debt Issued, Total	7.14B	10.38B	8.88B	11.41B	6.84B
Total Debt Issued	7.44B	10.54B	9B	11.41B	6.84B
Short Term Debt Repaid, Total	-694M	-140M	-	-	-
Long-Term Debt Repaid, Total	-6.94B	-9.55B	-6.4B	-9.53B	-7.3B
Total Debt Repaid	-7.63B	-9.69B	-6.4B	-9.53B	-7.3B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.1B	-	-	-	-
Common Dividends Paid	-1.32B	-1.52B	-1.5B	-1.22B	-797M
Common & Preferred Stock Dividends Paid	-1.32B	-1.52B	-1.5B	-1.22B	-797M
Other Financing Activities, Total	262M	4.25B	-800M	-424M	-72.43M
Cash from Financing	-2.35B	3.59B	307M	241M	-1.33B
Foreign Exchange Rate Adjustments	-22.33M	31.33M	19.38M	16.32M	2.23M
Net Change in Cash	-258M	3.11B	-2.36B	-649M	373M
Supplemental Items
Cash Interest Paid	-	16.87M	28.84M	21.69M	14.73M
Cash Income Tax Paid (Refund)	1.31B	903M	1.18B	708M	1.23B
Levered Free Cash Flow	1.34B	-1.69B	-3.99B	-629M	175M
Unlevered Free Cash Flow	1.63B	-1.38B	-3.74B	-381M	403M
Change In Net Working Capital	163M	332M	-438M	-1.49B	-261M
Net Debt Issued / Repaid	-193M	858M	2.61B	1.88B	-464M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.39	4.53	3.24	0.88	2
Return on Total Capital	8.86	6.17	4.43	1.2	2.8
Return On Equity %	23.49	19.56	10.39	4.22	7.59
Return on Common Equity	24.75	22.33	12.06	4.8	9.46
Margin Analysis
Gross Profit Margin %	29.7	25.22	23.8	16.69	18.55
SG&A Margin	6.21	5.79	6.85	6.69	5.89
EBITDA Margin %	24.22	20.4	17.58	11.73	14.08
EBITA Margin %	18.63	14.37	11.44	4.14	7.2
EBIT Margin %	18.18	13.85	10.98	3.43	6.65
Income From Continuing Operations Margin %	17.12	16.88	10.49	4.69	6.92
Net Income Margin %	16.62	15.88	8.59	3.72	6.02
Net Avail. For Common Margin %	16.62	15.88	8.59	3.72	6.02
Normalized Net Income Margin	9.57	6.91	4.12	0.41	2.54
Levered Free Cash Flow Margin	6.63	-7.66	-15.42	-2.62	0.58
Unlevered Free Cash Flow Margin	8.04	-6.26	-14.44	-1.59	1.34
Asset Turnover
Asset Turnover	0.56	0.52	0.47	0.41	0.48
Fixed Assets Turnover	1.08	1	0.91	0.72	0.84
Receivables Turnover (Average Receivables)	2.42	2.32	2.02	1.95	2.3
Inventory Turnover (Average Inventory)	6.5	6.09	5.15	5.33	5.96
Short Term Liquidity
Current Ratio	1.06	1.46	1.11	0.97	0.93
Quick Ratio	0.84	1.19	0.85	0.72	0.69
Operating Cash Flow to Current Liabilities	0.27	0.24	0.25	0.18	0.21
Days Sales Outstanding (Average Receivables)	150.85	157.01	181.13	187.93	159.02
Days Outstanding Inventory (Average Inventory)	56.19	59.91	70.84	68.6	61.23
Average Days Payable Outstanding	168.62	166.47	201.32	212.87	201.35
Cash Conversion Cycle (Average Days)	38.42	50.46	50.65	43.66	18.89
Long Term Solvency
Total Debt/Equity	72.61	55.72	57.57	64.66	60.88
Total Debt / Total Capital	42.07	35.78	36.54	39.27	37.84
LT Debt/Equity	42.89	43.51	36.98	42.52	35.04
Long-Term Debt / Total Capital	24.85	27.94	23.47	25.82	21.78
Total Liabilities / Total Assets	58.51	51.92	53.35	55.34	56.79
EBIT / Interest Expense	8.04	6.16	7.02	2.07	5.49
EBITDA / Interest Expense	10.74	9.12	11.36	7.26	11.82
(EBITDA - Capex) / Interest Expense	6.81	-0.01	-7.83	-4.25	2.08
Total Debt / EBITDA	2.3	2.77	3.32	6.01	4
Net Debt / EBITDA	1.77	1.49	2.55	5.06	3.28
Total Debt / (EBITDA - Capex)	3.63	-4.7K	-4.81	-10.26	22.68
Net Debt / (EBITDA - Capex)	2.78	-2.54K	-3.7	-8.63	18.6
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.58	8.94	0.29	-7.37	25.9
Gross Profit, 1 Yr. Growth %	20.62	-7.52	2.83	-33.07	39.94
EBITDA, 1 Yr. Growth %	27.73	-8.44	-9.22	-38.88	22.44
EBITA, 1 Yr. Growth %	33.68	-16.19	-17.08	-66.61	31.68
EBIT, 1 Yr. Growth %	35.92	-17.04	-17.43	-71.04	37.64
Earnings From Cont. Operations, 1 Yr. Growth %	78.78	7.37	-29.09	-58.59	85.8
Net Income, 1 Yr. Growth %	65.4	4.08	-37.77	-59.89	103.82
Normalized Net Income, 1 Yr. Growth %	30.73	-21.34	-38.54	-90.74	52.33
Diluted EPS Before Extra, 1 Yr. Growth %	65.39	4.08	-37.77	-59.88	103.8
Accounts Receivable, 1 Yr. Growth %	13.87	12.62	-3.06	-6.37	23.65
Inventory, 1 Yr. Growth %	5.04	41.2	4.06	-8.21	30.16
Net Property, Plant and Equip., 1 Yr. Growth %	12.94	20.09	23.08	13.08	2.72
Total Assets, 1 Yr. Growth %	8.72	24.62	7.76	5.22	9.57
Tangible Book Value, 1 Yr. Growth %	9.7	22.34	-1.08	-0.62	8.9
Common Equity, 1 Yr. Growth %	8.22	21.92	1.32	-0.56	7.55
Cash From Operations, 1 Yr. Growth %	12.21	-13.95	59.01	-25.34	50.05
Capital Expenditures, 1 Yr. Growth %	-33.5	151.56	66.52	-41.25	-22.07
Levered Free Cash Flow, 1 Yr. Growth %	-1.28K	-226.01	39.89	-83.99	-175.09
Unlevered Free Cash Flow, 1 Yr. Growth %	969.97	-184.8	47.19	-89.63	2.67K
Dividend Per Share, 1 Yr. Growth %	58.75	3.94	-15.15	-59.82	92.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	22.2	8.26	12.94	-3.61	7.99
Gross Profit, 2 Yr. CAGR %	34.23	5.62	1.09	-18.27	-3.22
EBITDA, 2 Yr. CAGR %	31.24	8.25	-3.87	-25.11	-3.86
EBITA, 2 Yr. CAGR %	40.7	5.98	-11.59	-47.3	-14.44
EBIT, 2 Yr. CAGR %	42.77	6.19	-12.26	-51.12	-15.94
Earnings From Cont. Operations, 2 Yr. CAGR %	55.97	38.55	-11.6	-45.82	-12.28
Net Income, 2 Yr. CAGR %	56.35	31.21	-18.8	-50.05	-9.58
Normalized Net Income, 2 Yr. CAGR %	51.08	1.4	-25.94	-76.3	-14.54
Diluted EPS Before Extra, 2 Yr. CAGR %	56.35	31.21	-18.8	-50.05	-9.58
Accounts Receivable, 2 Yr. CAGR %	19.19	13.24	18.66	-4.72	7.6
Inventory, 2 Yr. CAGR %	2.27	21.78	31.73	-2.26	9.3
Net Property, Plant and Equip., 2 Yr. CAGR %	12.49	16.46	25.02	18.11	7.78
Total Assets, 2 Yr. CAGR %	13.35	16.4	22.87	6.57	7.37
Tangible Book Value, 2 Yr. CAGR %	11.55	15.85	12.71	-0.73	4.03
Common Equity, 2 Yr. CAGR %	9.95	14.86	14.46	0.52	3.42
Cash From Operations, 2 Yr. CAGR %	11.2	-1.74	14.57	8.98	5.84
Capital Expenditures, 2 Yr. CAGR %	-8.97	29.34	107.5	-1.09	-32.34
Levered Free Cash Flow, 2 Yr. CAGR %	475.93	285.03	72.28	-53.05	-78.89
Unlevered Free Cash Flow, 2 Yr. CAGR %	194.88	201.22	51.36	-61.26	-66.87
Dividend Per Share, 2 Yr. CAGR %	56.28	28.45	-6.09	-41.61	-11.97
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.16	17.61	11.13	5.72	5.36
Gross Profit, 3 Yr. CAGR %	25.69	18.55	7.22	-12.76	-2.22
EBITDA, 3 Yr. CAGR %	27.41	16.48	5.76	-17.04	-5.34
EBITA, 3 Yr. CAGR %	32.24	18.48	1.56	-36.02	-15.24
EBIT, 3 Yr. CAGR %	33.08	19.14	1.53	-39.38	-16.46
Earnings From Cont. Operations, 3 Yr. CAGR %	54.02	37.72	11.8	-31.35	-18.3
Net Income, 3 Yr. CAGR %	53.66	36.52	2.93	-35.82	-20.18
Normalized Net Income, 3 Yr. CAGR %	42.33	21.54	-10.49	-63.13	-23.77
Diluted EPS Before Extra, 3 Yr. CAGR %	55.69	36.52	2.93	-35.82	-20.18
Accounts Receivable, 3 Yr. CAGR %	15.52	16.96	17.04	9.66	3.93
Inventory, 3 Yr. CAGR %	9.63	13.88	22.15	16.79	7.53
Net Property, Plant and Equip., 3 Yr. CAGR %	16.31	14.97	20.86	21	12.74
Total Assets, 3 Yr. CAGR %	16.05	16.99	17.96	16.74	7.56
Tangible Book Value, 3 Yr. CAGR %	11.03	15.04	11.7	8.17	2.39
Common Equity, 3 Yr. CAGR %	10.06	13.8	12.34	9.32	2.81
Cash From Operations, 3 Yr. CAGR %	32.92	2.09	13.78	-0.66	21.24
Capital Expenditures, 3 Yr. CAGR %	1.77	27.74	42	36.25	-8.65
Levered Free Cash Flow, 3 Yr. CAGR %	112.79	247.04	226.86	-22.38	-60.55
Unlevered Free Cash Flow, 3 Yr. CAGR %	178.22	94.64	190.5	-38.41	-45.84
Dividend Per Share, 3 Yr. CAGR %	50.33	36.41	11.87	-29.24	-13.04
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	18.46	16.65	17.8	12.03	9.86
Gross Profit, 5 Yr. CAGR %	21.41	14.62	15.2	3.65	2.31
EBITDA, 5 Yr. CAGR %	24.68	14.91	13.88	-0.29	2.02
EBITA, 5 Yr. CAGR %	33.84	17.15	12.63	-12.27	-5.11
EBIT, 5 Yr. CAGR %	35.45	17.47	12.66	-14.61	-5.87
Earnings From Cont. Operations, 5 Yr. CAGR %	49.86	35.71	23.35	-4.68	1.45
Net Income, 5 Yr. CAGR %	53.07	35.55	19.06	-8.36	-2.28
Normalized Net Income, 5 Yr. CAGR %	37.32	21.29	9.6	-35.18	-12.37
Diluted EPS Before Extra, 5 Yr. CAGR %	48.68	35.55	20	-8.36	-2.28
Accounts Receivable, 5 Yr. CAGR %	16.36	13.77	16.77	13.38	13.18
Inventory, 5 Yr. CAGR %	8.56	11.65	17.99	10.75	16.85
Net Property, Plant and Equip., 5 Yr. CAGR %	13.54	15.65	19.72	17.52	15.49
Total Assets, 5 Yr. CAGR %	12.83	15.88	18.73	15.37	13.64
Tangible Book Value, 5 Yr. CAGR %	13.1	15.44	11.7	9.51	8.62
Common Equity, 5 Yr. CAGR %	12.14	14.51	11.8	9.57	8.75
Cash From Operations, 5 Yr. CAGR %	27.68	32.62	25.25	3.93	10.54
Capital Expenditures, 5 Yr. CAGR %	6.68	23.98	35.33	15.95	5.56
Levered Free Cash Flow, 5 Yr. CAGR %	43.38	10	95.55	73.04	8.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	171.35	10.21	118.09	15.23	21.48
Dividend Per Share, 5 Yr. CAGR %	38.3	35.56	24.54	-2.85	1.64